Summary of percentage tumor-free mice at endpoint of experiment described in Fig. 2
| Treatment group | Tumor-free /total mice replicate 1 | Tumor-free /total mice replicate 2 | Combined percent tumor free | Statistical significance | ||
| versus 6 × 106 | versus 0 | versus naive | ||||
| 103 | 11 / 14 | 12 / 16 | 77% | P < 0.01 | P < 0.001a | P < 0.001a |
| 105 | 11 / 15 | 14 / 16 | 81% | P < 0.01 | P < 0.001a | P < 0.001a |
| 106 | 10 / 15 | 9 / 16 | 52% | P < 0.05 | P < 0.001a | |
| 6 × 106 | 5 / 12 | 5 / 15 | 37% | |||
| 0 (no pmel) | 6 / 14 | 2 / 15 | 28% | |||
| Naive | 1 / 10 | 3 / 15 | 16% | |||
| Treatment group | Tumor-free /total mice replicate 1 | Tumor-free /total mice replicate 2 | Combined percent tumor free | Statistical significance | ||
| versus 6 × 106 | versus 0 | versus naive | ||||
| 103 | 11 / 14 | 12 / 16 | 77% | P < 0.01 | P < 0.001 | P < 0.001 |
| 105 | 11 / 15 | 14 / 16 | 81% | P < 0.01 | P < 0.001 | P < 0.001 |
| 106 | 10 / 15 | 9 / 16 | 52% | P < 0.05 | P < 0.001 | |
| 6 × 106 | 5 / 12 | 5 / 15 | 37% | |||
| 0 (no pmel) | 6 / 14 | 2 / 15 | 28% | |||
| Naive | 1 / 10 | 3 / 15 | 16% | |||
Endpoint was day 104 (replicate 1) and day 131 (replicate 2) post-tumor challenge. Statistical significance was calculated for combined experiment.
Indicates values remaining significant after correction for multiple comparisons.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.